Nasalgen IP Vaccine

Supplied By: Merck (065387)


SKU
011517


Unit of
Measure
50 Dose


Pack
Type
Vial


Case
Qty
1

{{promo.PromoName}}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}

Jan- 2025 Dec- 2024 Nov- 2024 Oct- 2024 Sep- 2024 Aug- 2024 Jul- 2024 Jun- 2024 May- 2024 Apr- 2024 Mar- 2024 Feb- 2024 Jan- 2024
{{purchaseHistoryItem}}


SKU
011517


Size
50 Dose

Case
Qty
1

Purchase History

Jan- 2025 {{productPurchaseHistory['011517'][0]}} Jun- 2024 {{productPurchaseHistory['011517'][0+7]}}
Dec- 2024 {{productPurchaseHistory['011517'][1]}} May- 2024 {{productPurchaseHistory['011517'][1+7]}}
Nov- 2024 {{productPurchaseHistory['011517'][2]}} Apr- 2024 {{productPurchaseHistory['011517'][2+7]}}
Oct- 2024 {{productPurchaseHistory['011517'][3]}} Mar- 2024 {{productPurchaseHistory['011517'][3+7]}}
Sep- 2024 {{productPurchaseHistory['011517'][4]}} Feb- 2024 {{productPurchaseHistory['011517'][4+7]}}
Aug- 2024 {{productPurchaseHistory['011517'][5]}} Jan- 2024 {{productPurchaseHistory['011517'][5+7]}}
Jul- 2024 {{productPurchaseHistory['011517'][6]}}
{{promo.PromoName }}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}

Compare Products

{{compareProd.sku}}

{{compareProd.desc}}

{{compareMessage}}

Product Description

Designed for convenience, the original BOVILIS® NASALGEN® IP vaccination is an aid in the prevention of disease caused by infectious bovine rhinotracheitis (IBR) and parainfluenza 3 (PI3) viruses.

Features & Benefits

  • Provides rapid onset of protection
  • No temperature sensitivity issues that would negatively impact replication once administered
  • Stimulates local production of antibodies at the site where infectious pathogens enter the respiratory system — the mucosal lining of the nasal cavity